Beijing Balance Medical Technology Co Ltd
SSE:688198
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Balance Medical Technology Co Ltd
SSE:688198
|
CN |
|
C
|
CP All PCL
SET:CPALL
|
TH |
|
P
|
Pollux Properties Indonesia Tbk PT
IDX:POLL
|
ID |
|
CURO Group Holdings Corp
OTC:CUROQ
|
US |
|
Apcotex Industries Ltd
NSE:APCOTEXIND
|
IN |
|
Remgro Ltd
OTC:RMGOF
|
ZA |
|
N
|
Neptune Co
KOSDAQ:217270
|
KR |
|
J
|
Jiangxi Fushine Pharmaceutical Co Ltd
SZSE:300497
|
CN |
|
C
|
Community Health Systems Inc
SWB:CG5
|
US |
|
Performance Food Group Co
NYSE:PFGC
|
US |
|
N
|
Ningxia Jiaze Renewables Corp Ltd
SSE:601619
|
CN |
|
Kidztech Holdings Ltd
HKEX:6918
|
CN |
|
Shoals Technologies Group Inc
NASDAQ:SHLS
|
US |
|
Orient Overseas (International) Ltd
HKEX:316
|
HK |
|
Radcom Ltd
NASDAQ:RDCM
|
IL |
|
H
|
Heineken Holding NV
OTC:HKHHF
|
NL |
|
New World Department Store China Ltd
HKEX:825
|
HK |
|
Jiangxi Guotai Group Co Ltd
SSE:603977
|
CN |
|
Mount Logan Capital Inc
OTC:PYCFF
|
CA |
|
Canadian Apartment Properties Real Estate Investment Trust
TSX:CAR.UN
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
Beijing Balance Medical Technology Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 97.7 CNY,
Beijing Balance Medical Technology Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Beijing Balance Medical Technology Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Beijing Balance Medical Technology Co Ltd
SSE:688198
|
13.5B CNY | 22.8 | 74.6 | 72.9 | 72.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |